{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:23:45Z","timestamp":1760549025903},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T00:00:00Z","timestamp":1288742400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s10157-010-0361-5","type":"journal-article","created":{"date-parts":[[2010,11,2]],"date-time":"2010-11-02T14:15:51Z","timestamp":1288707351000},"page":"92-99","source":"Crossref","is-referenced-by-count":12,"title":["Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease"],"prefix":"10.1007","volume":"15","author":[{"given":"Charumathi","family":"Sabanayagam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"361_CR1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1681\/ASN.2005121288","volume":"17","author":"CD Stehouwer","year":"2006","unstructured":"Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol. 2006;17:2106\u201311.","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl 4","key":"361_CR2","first-page":"64","volume":"26","author":"B Feldt-Rasmussen","year":"2000","unstructured":"Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 2000;26(Suppl 4):64\u20136.","journal-title":"Diabetes Metab"},{"key":"361_CR3","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777\u201382.","journal-title":"Circulation"},{"key":"361_CR4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2796.2001.00833.x","volume":"249","author":"HL Hillege","year":"2001","unstructured":"Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519\u201326.","journal-title":"J Intern Med"},{"key":"361_CR5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002;325:1202.","journal-title":"BMJ"},{"key":"361_CR6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131:363\u201375.","journal-title":"Ann Intern Med"},{"key":"361_CR7","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/diacare.24.10.1805","volume":"24","author":"L Davies","year":"2001","unstructured":"Davies L, Wilmshurst EG, McElduff A, Gunton J, Clifton-Bligh P, Fulcher GR. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care. 2001;24:1805\u20139.","journal-title":"Diabetes Care"},{"key":"361_CR8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diacare.21.6.1028","volume":"21","author":"VA Fonseca","year":"1998","unstructured":"Fonseca VA, Reynolds T, Fink LM. Hyperhomocysteinemia and microalbuminuria in diabetes. Diabetes Care. 1998;21:1028.","journal-title":"Diabetes Care"},{"key":"361_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00125-003-1104-x","volume":"46","author":"HC Looker","year":"2003","unstructured":"Looker HC, Fagot-Campagna A, Gunter EW, et al. Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. Diabetologia. 2003;46:766\u201372.","journal-title":"Diabetologia"},{"key":"361_CR10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s001250051168","volume":"42","author":"YM Smulders","year":"1999","unstructured":"Smulders YM, Brouwer CB, Silberbusch J. Is plasma homocysteine related to albumin excretion rate in patients with diabetes mellitus? Diabetologia. 1999;42:382\u20133.","journal-title":"Diabetologia"},{"key":"361_CR11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2005.01560.x","volume":"258","author":"SS Soedamah-Muthu","year":"2005","unstructured":"Soedamah-Muthu SS, Chaturvedi N, Teerlink T, Idzior-Walus B, Fuller JH, Stehouwer CD. Plasma homocysteine and microvascular and macrovascular complications in type 1 diabetes: a cross-sectional nested case-control study. J Intern Med. 2005;258:450\u20139.","journal-title":"J Intern Med"},{"key":"361_CR12","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1464-5491.2006.01980.x","volume":"23","author":"F Wotherspoon","year":"2006","unstructured":"Wotherspoon F, Laight DW, Browne DL, et al. Plasma homocysteine, oxidative stress and endothelial function in patients with Type 1 diabetes mellitus and microalbuminuria. Diabetes Med. 2006;23:1350\u20136.","journal-title":"Diabetes Med"},{"key":"361_CR13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2337\/diacare.25.3.632","volume":"25","author":"JM Gonzalez-Clemente","year":"2002","unstructured":"Gonzalez-Clemente JM, Deulofeu R, Mitjavila J, et al. Plasma homocysteine is not increased in microalbuminuric patients with type 2 diabetes without clinical cardiovascular disease. Diabetes Care. 2002;25:632\u20133.","journal-title":"Diabetes Care"},{"key":"361_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0168-8227(00)00193-5","volume":"50","author":"N Abdella","year":"2000","unstructured":"Abdella N, Mojiminiyi OA, Akanji AO. Homocysteine and endogenous markers of renal function in type 2 diabetic patients without coronary heart disease. Diabetes Res Clin Pract. 2000;50:177\u201385.","journal-title":"Diabetes Res Clin Pract"},{"key":"361_CR15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","volume":"66","author":"ME Francis","year":"2004","unstructured":"Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int. 2004;66:303\u201312.","journal-title":"Kidney Int"},{"key":"361_CR16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","volume":"21","author":"A Jager","year":"2001","unstructured":"Jager A, Kostense PJ, Nijpels G, et al. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001;21:74\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"361_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1749-6632.1992.tb17100.x","volume":"669","author":"JB Mason","year":"1992","unstructured":"Mason JB, Miller JW. The effects of vitamins B12, B6, and folate on blood homocysteine levels. Ann N Y Acad Sci. 1992;669:197\u2013203.","journal-title":"Ann N Y Acad Sci"},{"key":"361_CR18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/ndt\/gfm485","volume":"23","author":"JF Mann","year":"2008","unstructured":"Mann JF, Sheridan P, McQueen MJ, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease\u2013\u2013results of the renal Hope-2 study. Nephrol Dial Transplant. 2008;23:645\u201353.","journal-title":"Nephrol Dial Transplant"},{"key":"361_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s005920200033","volume":"39","author":"NA Abdella","year":"2002","unstructured":"Abdella NA, Mojiminiyi OA, Akanji AO, Moussa MA. Associations of plasma homocysteine concentration in subjects with type 2 diabetes mellitus. Acta Diabetol. 2002;39:183\u201390.","journal-title":"Acta Diabetol"},{"key":"361_CR20","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/ajcn\/69.3.482","volume":"69","author":"PF Jacques","year":"1999","unstructured":"Jacques PF, Rosenberg IH, Rogers G, et al. Serum total homocysteine concentrations in adolescent and adult Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 1999;69:482\u20139.","journal-title":"Am J Clin Nutr"},{"key":"361_CR21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0021-9150(02)00024-2","volume":"164","author":"FP Cappuccio","year":"2002","unstructured":"Cappuccio FP, Bell R, Perry IJ, et al. Homocysteine levels in men and women of different ethnic and cultural background living in England. Atherosclerosis. 2002;164:95\u2013102.","journal-title":"Atherosclerosis"},{"key":"361_CR22","unstructured":"National Center for Health Statistics. The Third National Health and Nutrition Examination Survey: reference manuals and reports. 1996. http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nh3rrm.htm . Accessed 29 Apr 2010."},{"key":"361_CR23","unstructured":"National Center for Health Statistics. Analytic and reporting guidelines: NHANES III. 1996. http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes3\/nh3gui.pdf . Accessed 29 Apr 2010."},{"key":"361_CR24","unstructured":"National Center for Health Statistics. Laboratory procedures used for NHANES III. 1996. http:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes3\/cdrom\/nchs\/manuals\/labman.pdf . Accessed 29 Apr 2010."},{"key":"361_CR25","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Clinical Practice Recommendations 2001. Diabetes Care. 2001; 24(Suppl 1): S1\u2013133.","DOI":"10.2337\/diacare.24.1.154"},{"key":"361_CR26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(02)70081-4","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"361_CR27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","volume":"422","author":"A Araki","year":"1987","unstructured":"Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43\u201352.","journal-title":"J Chromatogr"},{"key":"361_CR28","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","volume":"30","author":"American Diabetes Association","year":"2007","unstructured":"American Diabetes Association. Standards of Medical Care in Diabetes\u2013\u20132007. Diabetes Care. 2007;30:S4\u201341.","journal-title":"Diabetes Care"},{"key":"361_CR29","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"361_CR30","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1053\/ajkd.2002.32765","volume":"39","author":"J Coresh","year":"2002","unstructured":"Coresh J, Astor BC, McQuillan G, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis. 2002;39:920\u20139.","journal-title":"Am J Kidney Dis"},{"key":"361_CR31","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/STROKEAHA.109.573410","volume":"41","author":"M Lee","year":"2010","unstructured":"Lee M, Hong KS, Chang SC, Saver JL. Efficacy of homocysteine-lowering therapy with folic acid in stroke prevention: a meta-analysis. Stroke. 2010;41:1205\u201312.","journal-title":"Stroke"},{"key":"361_CR32","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/jama.299.17.2027","volume":"299","author":"CM Albert","year":"2008","unstructured":"Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA. 2008;299:2027\u201336.","journal-title":"JAMA"},{"key":"361_CR33","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s001250050969","volume":"41","author":"A Chico","year":"1998","unstructured":"Chico A, Perez A, Cordoba A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia. 1998;41:684\u201393.","journal-title":"Diabetologia"},{"key":"361_CR34","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/diacare.25.11.2037","volume":"25","author":"AN Friedman","year":"2002","unstructured":"Friedman AN, Hunsicker LG, Selhub J, Bostom AG. Proteinuria as a predictor of total plasma homocysteine levels in type 2 diabetic nephropathy. Diabetes Care. 2002;25:2037\u201341.","journal-title":"Diabetes Care"},{"key":"361_CR35","first-page":"279","volume":"32","author":"B Ozmen","year":"2002","unstructured":"Ozmen B, Ozmen D, Turgan N, Habif S, Mutaf I, Bayindir O. Association between homocysteinemia and renal function in patients with type 2 diabetes mellitus. Ann Clin Lab Sci. 2002;32:279\u201386.","journal-title":"Ann Clin Lab Sci"},{"key":"361_CR36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1463-1326.2004.00376.x","volume":"7","author":"AN Elias","year":"2005","unstructured":"Elias AN, Eng S. Homocysteine concentrations in patients with diabetes mellitus\u2013\u2013relationship to microvascular and macrovascular disease. Diabetes Obes Metab. 2005;7:117\u201321.","journal-title":"Diabetes Obes Metab"},{"key":"361_CR37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.ki.4495353","volume":"54","author":"EK Hoogeveen","year":"1998","unstructured":"Hoogeveen EK, Kostense PJ, Jager A, et al. Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int. 1998;54:203\u20139.","journal-title":"Kidney Int"},{"key":"361_CR38","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000101471","volume":"27","author":"F Yi","year":"2007","unstructured":"Yi F, dos Santos EA, Xia M, Chen QZ, Li PL, Li N. Podocyte injury and glomerulosclerosis in hyperhomocysteinemic rats. Am J Nephrol. 2007;27:262\u20138.","journal-title":"Am J Nephrol"},{"key":"361_CR39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000110876","volume":"28","author":"F Yi","year":"2008","unstructured":"Yi F, Li PL. Mechanisms of homocysteine-induced glomerular injury and sclerosis. Am J Nephrol. 2008;28:254\u201364.","journal-title":"Am J Nephrol"},{"key":"361_CR40","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0024-3205(97)00392-5","volume":"61","author":"SR Lentz","year":"1997","unstructured":"Lentz SR. Homocysteine and vascular dysfunction. Life Sci. 1997;61:1205\u201315.","journal-title":"Life Sci"},{"key":"361_CR41","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/biof.17","volume":"35","author":"J Zhou","year":"2009","unstructured":"Zhou J, Austin RC. Contributions of hyperhomocysteinemia to atherosclerosis: causal relationship and potential mechanisms. Biofactors. 2009;35:120\u20139.","journal-title":"Biofactors"},{"key":"361_CR42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000114300","volume":"31","author":"A Shankar","year":"2008","unstructured":"Shankar A, Wang JJ, Chua B, Rochtchina E, Flood V, Mitchell P. Positive association between plasma homocysteine level and chronic kidney disease. Kidney Blood Press Res. 2008;31:55\u201362.","journal-title":"Kidney Blood Press Res"},{"key":"361_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1464-5491.2001.00445.x","volume":"18","author":"A Ambrosch","year":"2001","unstructured":"Ambrosch A, Dierkes J, Lobmann R, et al. Relation between homocysteinaemia and diabetic neuropathy in patients with Type 2 diabetes mellitus. Diabet Med. 2001;18:185\u201392.","journal-title":"Diabet Med"},{"key":"361_CR44","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"Homocysteine Studies Collaboration","year":"2002","unstructured":"Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015\u201322.","journal-title":"JAMA"},{"key":"361_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","volume":"41","author":"J Coresh","year":"2003","unstructured":"Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1\u201312.","journal-title":"Am J Kidney Dis"},{"key":"361_CR46","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1681\/ASN.2004070539","volume":"16","author":"J Coresh","year":"2005","unstructured":"Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180\u20138.","journal-title":"J Am Soc Nephrol"},{"key":"361_CR47","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1681\/ASN.V1341034","volume":"13","author":"HJ Mattix","year":"2002","unstructured":"Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin\/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol. 2002;13:1034\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"361_CR48","first-page":"141","volume":"27","author":"S Asnani","year":"2002","unstructured":"Asnani S, Desouza C, Homan J, Murthy SN, McNamara DB, Fonseca V. Hormones and homocysteine. Minerva Endocrinol. 2002;27:141\u201355.","journal-title":"Minerva Endocrinol."},{"key":"361_CR49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1161\/hq0302.104515","volume":"22","author":"T Ide","year":"2002","unstructured":"Ide T, Tsutsui H, Ohashi N, et al. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol. 2002;22:438\u201342.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"361_CR50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1161\/01.ATV.20.2.493","volume":"20","author":"JM Foody","year":"2000","unstructured":"Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL. Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol. 2000;20:493\u20139.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"361_CR51","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2261-6-38","volume":"6","author":"S Sadeghian","year":"2006","unstructured":"Sadeghian S, Fallahi F, Salarifar M, et al. Homocysteine, vitamin B12, folate levels in premature coronary artery disease. BMC Cardiovasc Disord. 2006;6:38.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0361-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0361-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0361-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T02:53:33Z","timestamp":1685847213000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0361-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["361"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0361-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,3]]}}}